Nucleic acid amplification assays for detection of pathogens
AssigneesThe Broad Institute, Inc., Massachusetts Institute of Technology, President and Fellows of Harvard College
InventorsMary Lynn BANIECKI, Hayden METSKY, Pardis SABETI
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method for generating primers and/or probes for use in analyzing a sample which may comprise a pathogen target sequence comprising providing a set of input genomic sequence to one or more target pathogens, generating a set of target sequences from the set of input genomic sequences, identifying one or more highly conserved target sequences, and generating one or more primers, one or more probes, or a primer pair and probe combination based on the one or more conserved target sequences.
Claims17
A method for developing probes and primers to pathogens, comprising:
- providing a set of input genomic sequences to one or more target pathogens;
- generating a set of target sequences from the set of input genomic sequences;
- applying a set cover solving process to the set of target sequences to identify one or more target amplification sequences, wherein the one or more target amplification sequences are highly conserved target sequences shared between the set of input genomic sequences of the target pathogen;
- and
- generating one or more primers, one or more probes, or a primer pair and probe combination based on the one or more target amplification sequences.
The method of claim 7, wherein the parasitic pathogen is Babesia microti.
A method for detecting Ebola in samples, comprising:
- contacting a sample with a forward and reverse primer and a probe with a detectable label, wherein the forward primer comprises SEQ ID NO:
- 1, the reverse primer comprises SEQ ID NO:
- 2, and the probe comprises SEQ ID NO:
- 3;
- and
- detecting amplification of one or more target sequences by quantitative PCR using the forward primer, reverse primer, and the probe, wherein detection of the one or more target sequences indicates the presence of Ebola.
A method for detecting Dengue in samples, comprising:
- contacting a sample with a forward and reverse primer and a probe with a detectable label, wherein the forward primer comprises SEQ ID NO:
- 45, the reverse primer comprises SEQ ID NO:
- 46, and the probe comprises SEQ ID NO:
- 47;
- and
- detecting amplification of one or more target sequences by quantitative PCR using the forward primer, reverse primer, and the probe, wherein detection of the one or more target sequences indicates the presence of Dengue.
A method for detecting Lassa in samples, comprising:
- contacting a sample with a forward and reverse primer wherein the forward primer comprises SEQ ID Nos:
- 50 or 56, the reverse primer comprises SEQ ID NOs:
- 54 or 57;
- and
- detecting amplification of one or more target sequences by quantitative PCR using the forward primer, reverse primer, and the probe, wherein detection of the one or more target sequences indicates the presence of Lassa.
A method for detecting Babesia microti in samples, comprising:
- contacting a sample with a forward and reverse primer and a probe with a detectable label, wherein the forward primer comprises SEQ ID NO:
- 49, the reverse primer comprises SEQ ID NO:
- 50, and the probe comprises SEQ ID NO:
- 51;
- and
- detecting amplification of one or more target sequences by quantitative PCR using the forward primer, reverse primer, and the probe, wherein detection of the one or more target sequences indicates the presence of Babesia microti.
Dependencies are inferred from the claim text.